Edge Therapeutics, Inc. 4
4 · Edge Therapeutics, Inc. · Filed Mar 13, 2017
Insider Transaction Report
Form 4
Einhorn Andrew J.
Chief Financial Officer
Transactions
- Exercise of In-Money
Common Stock
2017-03-01$2.39/sh+1,567$3,745→ 43,223 total - Exercise of In-Money
Warrants (right To Purchase)
2017-03-01−1,567→ 0 totalExercise: $2.39From: 2012-09-09Exp: 2017-09-09→ Common Stock (1,567 underlying)
Holdings
- 83,592(indirect: By LLC)
Common Stock
Footnotes (1)
- [F1]The Reporting Person is the sole managing member of Harpua, LLC and may be deemed to beneficially own these shares. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.